Bulk Inquiry
AT 9283
- Soluble in water and DMSO
- MF: C19H23N7O2
- MW: 381.43
Description
More Information
| Parent CAS No. | 896466-04-9 |
|---|---|
| Chemical Name | 1-cyclopropyl-3-(3-(6-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea |
| SMILES | N(C1CC1)C(NC1=CNN=C1C1NC2=CC(CN3CCOCC3)=CC=C2N=1)=O |
| MFCD | MFCD12031513 |
| InChi | InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27) |
| InChiKey | LOLPPWBBNUVNQZ-UHFFFAOYSA-N |
| CID | 135398495 |
| Short Description | Aurora/JAK inhibitor |
References
- W. Qi et al. AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas. Int. J. Cancer. 2012, 130, 2997-3005.
- R. Tanaka et al. Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cells. Blood. 2010, 116, 2089-2095.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1137 | PD180970 |
From $143.00 |
| 1338 | CP 690550 |
From $66.00 |
| 1378 | AG 490 |
From $71.50 |
| 1392 | Dasatinib |
From $99.00 |
| 1394 | Imatinib mesylate |
From $66.00 |
| 1396 | Nilotinib |
From $55.00 |
| 1407 | SKI 606 |
From $82.50 |
| 1540 | VX 680 |
From $66.00 |
| 1541 | ZM 447439 |
From $93.50 |
| 1580 | AZD1152-HQPA |
From $77.00 |
| 1588 | TG 101348 |
From $88.00 |
| 1597 | Aurora A inhibitor I |
From $137.50 |
| 1598 | Ruxolitinib |
From $71.50 |
| 1630 | Aurora A inhibitor II |
From $137.50 |
| 1681 | Momelotinib |
From $88.00 |
| 1778 | AZ 960 |
From $104.50 |
| 1783 | AMG 900 |
From $121.00 |
| 1836 | CCT 137690 |
From $126.50 |
| 1843 | JAK2 inhibitor 13 |
From $121.00 |
| 1857 | AP 24534 |
From $77.00 |
| 1882 | GNF 2 |
From $121.00 |
| 1955 | Baricitinib |
From $77.00 |
| 1961 | MK 5108 |
From $121.00 |
| 1992 | AS 1517499 |
From $143.00 |
